Researchers are excited about the medication , a groundbreaking dual compound showing promising outcomes in early trials for weight loss . It acts by impacting both systems: GLP-1 and GIP, which , when https://anniefhbb200259.myparisblog.com/41310125/a-new-prospect-for-weight-loss